H1 revenues took an inevitable hit from the reduction in elective surgeries globally, but SUN is showing agility in navigating the challenges. It is well capitalised and has made a number of internal improvements which should stand it in good stead as volumes recover. This recovery looks to be playing out ahead of expectations. We keep our forecasts under review for now, but the direction of travel looks encouraging and the medium term outlook positive given the fully upgraded product suite,
09 Sep 2020
Building back better
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Building back better
Surgical Innovations Group plc (SUN:LON) | 0.5 0 0.0% | Mkt Cap: 4.66m
- Published:
09 Sep 2020 -
Author:
Chris Glasper -
Pages:
3
H1 revenues took an inevitable hit from the reduction in elective surgeries globally, but SUN is showing agility in navigating the challenges. It is well capitalised and has made a number of internal improvements which should stand it in good stead as volumes recover. This recovery looks to be playing out ahead of expectations. We keep our forecasts under review for now, but the direction of travel looks encouraging and the medium term outlook positive given the fully upgraded product suite,